346
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

MAPK Genes Interact with Diet and Lifestyle Factors to Alter Risk of Breast Cancer: The Breast Cancer Health Disparities Study

, , , , , , , & show all
Pages 292-304 | Received 10 Mar 2014, Accepted 29 Oct 2014, Published online: 28 Jan 2015

REFERENCES

  • Imajo M, Tsuchiya Y, and Nishida E: Regulatory mechanisms and functions of MAP kinase signaling pathways. IUBMB Life 58, 312–317, 2006.
  • Qi M and Elion EA: MAP kinase pathways. J Cell Sci 118, 3569–3572, 2005.
  • Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, et al.: A central role for JNK in obesity and insulin resistance. Nature 420, 333–336, 2002.
  • Lee YH, Giraud J, Davis RJ, and White MF: c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem 278, 2896–2902, 2003.
  • Kamata H, Honda S, Maeda S, Chang L, Hirata H, et al.: Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649–661, 2005.
  • Lubos E, Kelly NJ, Oldebeken SR, Leopold JA, Zhang YY, et al.: Glutathione peroxidase-1 deficiency augments proinflammatory cytokine–induced redox signaling and human endothelial cell activation. J Biol Chem 286, 35407–35417, 2011.
  • Mulder KM: Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 11, 23–35, 2000.
  • Nasim MT, Ogo T, Chowdhury HM, Zhao L, Chen CN, et al.: BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFbeta-TAK1-MAPK pathways in PAH. Hum Mol Genet 21, 2548–2558, 2012.
  • To SQ, Knower KC, and Clyne CD: NFkappaB and MAPK signalling pathways mediate TNFalpha-induced Early Growth Response gene transcription leading to aromatase expression. Biochem Biophys Res Commun 433, 96–101, 2013.
  • Burns KA and Vanden Heuvel JP: Modulation of PPAR activity via phosphorylation. Biochim Biophys Acta 1771, 952–960, 2007.
  • Hu R and Kong AN: Activation of MAP kinases, apoptosis and nutrigenomics of gene expression elicited by dietary cancer-prevention compounds. Nutrition 20, 83–88, 2004.
  • Cappellani A, Di Vita M, Zanghi A, Cavallaro A, Piccolo G, et al.: Diet, obesity and breast cancer: an update. Front Biosci (Schol Ed) 4, 90–108, 2012.
  • Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, et al.: Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 111, 762–771, 2004.
  • Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, et al.: Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 13, 741–751, 2002.
  • John EM, Phipps AI, and Sangaramoorthy M: Body size, modifying factors, and postmenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area Breast Cancer Study. Springerplus 2, 239, 2013.
  • Abdel-Maksoud MF, Risendal BC, Slattery ML, Giuliano AR, Baumgartner KB, et al.: Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors. Breast Cancer Research and Treatment 131, 169–176, 2012.
  • Slattery ML, Sweeney C, Edwards S, Herrick J, Baumgartner K, et al.: Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat 102, 85–101, 2007.
  • Gaudet MM, Gapstur SM, Sun J, Diver WR, Hannan LM, et al.: Active smoking and breast cancer risk: original cohort data and meta-analysis. J Natl Cancer Inst 105, 515–525, 2013.
  • Bjerkaas E, Parajuli R, Weiderpass E, Engeland A, Maskarinec G, et al.: Smoking duration before first childbirth: an emerging risk factor for breast cancer? Results from 302,865 Norwegian women. Cancer Causes Control 24, 1347–1356, 2013.
  • Beasley JM, Coronado GD, Livaudais J, Angeles-Llerenas A, Ortega-Olvera C, et al.: Alcohol and risk of breast cancer in Mexican women. Cancer Causes Control 21, 863–870, 2010.
  • Bowlin SJ, Leske MC, Varma A, Nasca P, Weinstein A, et al.: Breast cancer risk and alcohol consumption: results from a large case-control study. Int J Epidemiol 26, 915–923, 1997.
  • Brooks PJ and Zakhari S: Moderate alcohol consumption and breast cancer in women: from epidemiology to mechanisms and interventions. Alcohol Clin Exp Res 37, 23–30, 2013.
  • Flatt SW, Thomson CA, Gold EB, Natarajan L, Rock CL, et al.: Low to moderate alcohol intake is not associated with increased mortality after breast cancer. Cancer Epidemiol Biomarkers Prev 19, 681–688, 2010.
  • Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, et al.: Type 2 diabetes and subsequent incidence of breast cancer in the Nurses’ Health Study. Diabetes Care 26, 1752–1758, 2003.
  • Redaniel MT, Jeffreys M, May MT, Ben-Shlomo Y, and Martin RM: Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women. Cancer Causes Control 23, 1785–1795, 2012.
  • Dalamaga M: Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets. World J Exp Med 3, 34–42, 2013.
  • Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN, and Hankinson SE: Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev 16, 161–164, 2007.
  • Murtaugh MA, Herrick J, Sweeney C, Guiliano A, Baumgartner K, et al.: Macronutrient composition influence on breast cancer risk in Hispanic and non-Hispanic white women: the 4-Corners Breast Cancer Study. Nutr Cancer 63, 185–195, 2011.
  • Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Herrick JS, et al.: Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population. Carcinogenesis 33, 1512–1521, 2012.
  • John EM, Horn-Ross PL, and Koo J: Lifetime physical activity and breast cancer risk in a multiethnic population: the San Francisco Bay area breast cancer study. Cancer Epidemiol Biomarkers Prev 12, 1143–1152, 2003.
  • John EM, Phipps AI, Davis A, and Koo J: Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomarkers Prev 14, 2905–2913, 2005.
  • Seinost G, Renner W, Brodmann M, Winkler M, Koppel H, et al.: C677T mutation in the methylene tetrahydrofolate reductase gene as a risk factor for venous thrombotic disease in Austrian patients. Thrombosis Research 100, 405–407, 2000.
  • Pradhan SJ, Mishra R, Sharma P, and Kundu GC: Quercetin and sulforaphane in combination suppress the progression of melanoma through the down-regulation of matrix metalloproteinase-9. Experimental and Therapeutic Medicine 1, 915–920, 2010.
  • Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Lewinger JP, et al.: Angiogenesis genes, dietary oxidative balance, and breast cancer risk and progression: The breast cancer health disparities study. Int J Cancer 134, 629–644, 2014.
  • Slattery ML, Caan BJ, Duncan D, Berry TD, Coates A, et al.: A computerized diet history questionnaire for epidemiologic studies. J Am Diet Assoc 94, 761–766, 1994.
  • Murtaugh MA, Sweeney C, Giuliano AR, Herrick JS, Hines L, et al.: Diet patterns and breast cancer risk in Hispanic and non-Hispanic white women: the Four-Corners Breast Cancer Study. Am J Clin Nutr 87, 978–984, 2008.
  • Hernandez-Avila M, Romieu I, Parra S, Hernandez-Avila J, Madrigal H, et al.: Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica de Mexico 40, 133–140, 1998.
  • Horn-Ross PL, John EM, Lee M, Stewart SL, Koo J, et al.: Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J Epidemiol 154, 434–441, 2001.
  • Falush D, Stephens M, and Pritchard JK: Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164, 1567–1587, 2003.
  • Pritchard JK, Stephens M, and Donnelly P: Inference of population structure using multilocus genotype data. Genetics 155, 945–959, 2000.
  • Yu K, Li Q, Bergen AW, Pfeiffer RM, Rosenberg PS, et al.: Pathway analysis by adaptive combination of P-values. Genetic Epidemiology 33, 700–709, 2009.
  • Kai Yu OL and William Wheeler: ARTP Gene and Pathway p-values computed using the Adaptive Rank Truncated Product. 2.0.0 ed. R package. 2011.
  • Li J and Ji L: Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95, 221–227, 2005.
  • Nyholt DR: A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. American Journal of Human Genetics 74, 765–769, 2004.
  • Rodriguez F, Naderi S, Wang Y, Johnson CE, and Foody JM: High prevalence of metabolic syndrome in young Hispanic women: findings from the national Sister to Sister campaign. Metab Syndr Relat Disord 11, 81–86, 2013.
  • Sentell TL, He G, Gregg EW, and Schillinger D: Racial/ethnic variation in prevalence estimates for United States prediabetes under alternative 2010 American Diabetes Association criteria: 1988–2008. Ethn Dis 22, 451–458, 2012.
  • Romero CX, Romero TE, Shlay JC, Ogden LG, and Dabelea D: Changing trends in the prevalence and disparities of obesity and other cardiovascular disease risk factors in three racial/ethnic groups of USA adults. Adv Prev Med 172423, 2012.
  • Dorow DS, Devereux L, Dietzsch E, and De Kretser T: Identification of a new family of human epithelial protein kinases containing two leucine/isoleucine-zipper domains. Eur J Biochem 213, 701–710, 1993.
  • Slattery ML, John EM, Torres-Mejia G, Herrick JS, Giuliano AR, et al.: Genetic variation in bone morphogenetic proteins and breast cancer risk in hispanic and non-hispanic white women: The breast cancer health disparities study. International Journal of Cancer/Journal International du Cancer 132, 2928–2939, 2013.
  • Kang Y: Pro-metastasis function of TGFbeta mediated by the Smad pathway. J Cell Biochem 98, 1380–1390, 2006.
  • Lei X, Bandyopadhyay A, Le T, and Sun L: Autocrine TGFbeta supports growth and survival of human breast cancer MDA-MB-231 cells. Oncogene 21, 7514–7523, 2002.
  • Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al.: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447, 1087–1093, 2007.
  • Gaudet MM, Kuchenbaecker KB, Vijai J, Klein RJ, Kirchhoff T, et al. Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet 9, e1003173, 2013.
  • Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, et al.: Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res 12, R110, 2010.
  • Slattery ML, Lundgreen A, and Wolff RK: MAP kinase genes and colon and rectal cancer. Carcinogenesis 33, 2398–2408, 2012.
  • Slattery ML, Lundgreen A, and Wolff RK: Dietary influence on MAPK-signaling pathways and risk of colon and rectal cancer. Nutr Cancer 65, 729–738, 2013.
  • Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, et al.: The landscape of cancer genes and mutational processes in breast cancer. Nature 486, 400–404, 2012.
  • Hori M, Inagawa S, Shimazaki J, Itabashi M, and Hori M: Overexpression of mitogen-activated protein kinase superfamily proteins unrelated to Ras and AF-1 of estrogen receptor alpha mutation in advanced stage human breast cancer. Pathol Res Pract 196, 817–826, 2000.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.